Automated Microbiology Market Size, Share, Industry, Forecast and outlook (2024-2031)

Automated Microbiology Market is Segmented by By Product (Instruments, Automated Culture Systems, Microbiology Analyzers, Reagents), By Diagnostic Technology (DNA & RNA Probe Technology, DNA sequencing, Detection Techniques, Monoclonal Antibodies, Non-Isotopic Methods, Radioactive Methods, Immunoassays), By End-User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Others ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Automated Microbiology Market Overview

The Global Automated Microbiology Market is estimated to reach high CAGR 9.1% during the forecast period (2024-2031). Automated microbiology is a cutting-edge technology for delivering more efficient, accurate, and timely test findings in microbiological research and development. Its quick results aid in detecting infections, including Ebola, chickenpox, smallpox, rubella, measles, mumps, influenza, and others. This technology automates crucial activities such as microbe separation, detection, categorization, and measurement in the biological, ecological, and food industries. 

Automated Microbiology Market Summary and Scope

Automated Microbiology Market Dynamics and Trends

A New Era in Clinical Microbiology with Automation and Molecular Diagnostics is expected to drive market growth.

Testing approaches based on organism growth on various liquid and solid media are being phased out in favor of newer methods that improve the pace of organism identification while also increasing sensitivity and specificity. Most of these new techniques are based on nucleic hybridization and polymerase-chain-reaction technology. They range from single-organism or organism family identification to multiplexed syndromic panels, which can simultaneously examine for the presence of multiple suspect organisms based on the patient's symptoms. Similarly, the clinical microbiology laboratory now has access to a level of automation previously only seen in the clinical laboratory's chemistry and hematology departments. Moreover, When appropriately implemented into the laboratory process, these transitions have been found to improve patient care. Collectively, the clinical microbiology laboratory is coming into a new era of technology and patient care that will bring about dramatic changes to conventional testing and organism identification. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

High costs and large footprints of these systems, and a scarcity of qualified personnel to operate them are the factors the market is expected to hamper in the forecast period.

Global Automated Microbiology Market - Industry Analysis

Porter’s Five Forces:

COVID-19 Impact Analysis on Automated Microbiology Market

The COVID-19 pandemic has moderately impacted healthcare systems and the market. Automated technologies assist in detecting infectious agents such as parasites, viroids, fungus, prions, bacteria, and viruses. For instance, the global COVID-19 tally topped 5 million in less than 5 months, indicating that diseases like COVID-19 create a huge demand for the automated sector. Also, the automated microbiology industry's expansion is spurred by the need for speedy results with high precision and growing health-related concerns. Additionally, the pandemic is interrupting the supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Automated Microbiology Market Segmentation Analysis

Clinical Laboratories segment is expected to hold the largest market share in automated microbiology market

The clinical laboratories segment is expected to dominate in 2020. The segment's growth benefits because of COVID-19's quick growth worldwide, increased microbiological research and development, increased investments in laboratory infrastructure development, and a growing emphasis on clinical laboratory automation. Moreover, the clinical microbiology laboratory saves time and enhances laboratory quality management by reducing its time to generate findings. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.

Automated Microbiology Market Geographical Share

North America region holds the largest market share in the global automated microbiology market

In 2020, North America accounted for the highest revenue share. The rising prevalence of infectious and chronic diseases, increased awareness of early disease diagnosis, increased microbiological research and development activities, technological advances in molecular diagnostics, and product launches by key players in the region are some of the factors due to which the market is expected to boost in the forecast period. For instance, according to the Centers for Disease Control and Prevention, it is estimated that On March 14, 2022, there were 81,174,677 cases and 993,811 deaths in the United States. Moreover, Becton, Dickinson and Company announced the BD Kiestra IdentifA system in November 2019. This solution accurately and efficiently prepares samples for microbiological identification. Therefore, it has increased the demand for automated microbiology instruments or analyzers in the region. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.      

Automated Microbiology Companies and Competitive Landscape

Major key players in the automated microbiology market are Becton Dickinson and Company, Microbiology International, Thermo Fisher Scientific, Inc., bioMérieux, Inc., Cardinal Health, Beckman Coulter, Inc., Merck KGaA, Rapid Micro Biosystems, Inc., Clever Culture Systems and Zhuhai Meihua Medical Technology Ltd.                       

Thermo Fisher Scientific:

Overview:

Thermo Fisher Scientific is an American company incorporated in 1956 and is based in Waltham, Massachusetts. The company offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services worldwide. Moreover, the global team has more than 90,000 colleagues who deliver an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

VersaTREK Automated Microbial Detection System:  The VersaTrek 528 is an automated BC microbial detection system produced by ThermoScientific. It detects pressure changes due to gas consumption (O2) and production (CO2, N2, H2, etc.) by microorganisms in a BC bottle. It is a more advanced and automated instrument than the single detection of CO2 production routinely used in several BC systems. It can detect bacterial pathogens that consume O2 without CO2 production. So it can provide a more credible and reliable result, improve recovery and reduce the TTDs of significant pathogens.